Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell, Peripheral × Methylprednisolone × Clear all

NCT03586999 2024-10-29

Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas

Phase 1/2 Completed

18 enrolled 14 charts

Lymphoma, T-Cell, Peripheral